Spotlight Innovation Unveils EPISORB
According to a media release, the product makes use of the attributes of cardiotoxin as a cell penetrating peptide and is intended for distribution through the compounding pharmacy industry.
Dr.
Celtic Biotech Iowa, a subsidiary of
More Information:
http://www.spotlightinnovation.com
((Comments on this story may be sent to [email protected]))
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News